Particology, a particle science company based at science and business hub Discovery Park, has been selected for an £8.2M Government-funded research consortium to make the manufacture of medicines more efficient and sustainable.
Covestro has announced the closing of its strategic partnership with XRG P.J.S.C. (formerly ADNOC International Limited, together with its subsidiaries in the following “XRG”).
Cellular Origins, a TTP company that enables the manufacturing of cell therapies at scale, has announced the completion of a $40 million over-subscribed Series A round.
Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country.
Aptamer Group, the developer of next-generation synthetic binders for the life sciences industry, has announced a new contract valued at up to £617,000 with a top-five pharmaceutical company.
Aenova, a contract development and manufacturing organisation (CDMO), announces an investment in its sterile manufacturing capabilities with the installation of another fill & finish (F&F) line at its Latina site.
Hovione, a fully-integrated global CDMO, has announced the completion of an initial multi-million-dollar investment cycle to expand its manufacturing campus in East Windsor, New Jersey.
Sharp Services, a company in pharmaceutical packaging, clinical trial services & sterile manufacturing has announced a $100 million investment across its global facility network to address increasing market demand for established and new medicines.
ACG, the world’s most integrated provider of solid-dosage solutions, has announced a $200 million phased investment to establish its first empty-capsule manufacturing operations in the United States.
One2Treat, a technology company transforming how the patient voice is integrated into clinical development, has announced the successful completion of a planned seed extension to accelerate its software platform development.
